Related Experiment Video
Updated: Jan 4, 2026

In Vitro Ubiquitination and Deubiquitination Assays of Nucleosomal Histones
Published on: July 25, 2019
Ubiquitin-specific peptidase 3 induces TPA-mediated leukemia cell differentiation via regulating H2AK119ub
Yun-Cheol Chae1, Hyeonsoo Jung1, Ji-Young Kim1
1Department of Life Science, College of Natural Sciences, Chung-Ang University, Seoul, South Korea.
Abstract:
Acute myeloid leukemia (AML) is the most common type of leukemia in adults. Owing to the chemotherapy associated side effects and toxicity, it is necessary to find a new mechanism, which can identify new potential therapeutic targets at the molecular level. Here, we identified new target genes that are induced during the TPA-induced HL-60 cell differentiation by ChIP-seq and microarray data analysis. Using q-PCR and ChIP assay, we confirmed that the target genes including USP3, USP35, TCF4, and SGK1 are upregulated during TPA-mediated HL-60 cell differentiation. Levels of USP3, one of the deubiquitinating enzymes (DUBs), increased by TPA treatment, resulting in the reduction of H2AK119ub levels. In addition, we revealed that depletion of USP3 inhibits TPA-mediated leukemia cell differentiation q-PCR and FACS analysis. Taken together, our data indicate that USP3 promotes TPA-mediated leukemia cell differentiation via regulating H2AK119ub levels.
Insights
Researchers identified USP3 as a key factor in promoting leukemia cell differentiation. USP3 regulates H2AK119ub levels, offering a potential new therapeutic target for acute myeloid leukemia (AML) treatment.
Area of Science:
- Molecular Biology
- Cancer Research
- Cellular Differentiation
Background:
- Acute myeloid leukemia (AML) is a prevalent adult cancer.
- Chemotherapy for AML presents significant side effects and toxicity.
- Identifying novel molecular targets is crucial for developing new AML therapies.
Purpose of the Study:
- To identify novel molecular targets for acute myeloid leukemia (AML) therapy.
- To investigate the role of specific genes in TPA-induced HL-60 cell differentiation.
Main Methods:
- Chromatin immunoprecipitation sequencing (ChIP-seq) and microarray analysis were employed to identify target genes.
- Quantitative PCR (q-PCR) and ChIP assays were used for validation.
- Flow cytometry analysis (FACS) assessed the impact of USP3 depletion on cell differentiation.
Main Results:
- Several genes, including USP3, USP35, TCF4, and SGK1, were found to be upregulated during TPA-mediated HL-60 cell differentiation.
- USP3, a deubiquitinating enzyme (DUB), increased upon TPA treatment, leading to decreased H2AK119ub levels.
- Depletion of USP3 significantly inhibited TPA-induced leukemia cell differentiation.
Conclusions:
- USP3 plays a critical role in promoting TPA-mediated differentiation of leukemia cells.
- USP3 regulates leukemia cell differentiation through modulation of H2AK119ub levels.
- USP3 represents a promising therapeutic target for acute myeloid leukemia.
Related Concept Videos
Abnormal Proliferation
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The Intrinsic Apoptotic Pathway
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...

